FindTrial
Sign In

Flagyl

DRUG6 trials

Sponsors

Par Pharmaceutical, Inc., Marjan Industria e Comercio ltda, Chang Gung Memorial Hospital

Conditions

Bacterial VaginosisFungal Vaginal InfectionsHelicobacter Pylori InfectionTo Determine the Bioequivalence Study Under FastingTo Determine the Bioequivalence Study Under Fed

Phase 1

Bioavailability Study of Metronidazole Capsules Under Fed Conditions
CompletedNCT01380522
Par Pharmaceutical, Inc.To Determine the Bioequivalence Study Under Fed
Start: 2002-08-31End: 2002-09-30Updated: 2011-06-27
Bioavailability Study of Metronidazole Capsules Under Fasting Conditions
CompletedNCT01380509
Par Pharmaceutical, Inc.To Determine the Bioequivalence Study Under Fasting
Start: 2002-08-31End: 2002-10-31Updated: 2011-06-27

Phase 3

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections
NCT02186145
Marjan Industria e Comercio ltdaBacterial Vaginosis, Fungal Vaginal Infections
Start: 2016-01-31End: 2017-01-31Target: 160Updated: 2015-04-09

Unknown Phase

Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication
CompletedNCT02596620
Chang Gung Memorial HospitalHelicobacter Pylori Infection
Start: 2013-10-31End: 2015-11-30Updated: 2017-02-28
Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
CompletedNCT03383003
Chang Gung Memorial HospitalHelicobacter Pylori Infection
Start: 2016-03-01End: 2018-05-01Updated: 2019-01-30
Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
CompletedNCT05152004
Chang Gung Memorial HospitalHelicobacter Pylori Infection
Start: 2018-09-01End: 2022-02-28Updated: 2022-07-20

Related Papers

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial.
2023-05-033 citations
A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
Medicine2016-05-0128 citations